Sheila Oren is a healthtech executive with over 25 years of experience leading drug and device development, particularly for neurological conditions. A co-founder and CEO, she has held senior roles at Teva, NeuroDerm, and Remepy, bringing a major Parkinsons drug from Phase 1 to market. She holds an MD from Tel Aviv University and an MBA from Reichman University.
Beyond her corporate roles, Sheila is a mentor and community leader dedicated to social impact through innovation. She leads the healthtech community for Next October, an initiative harnessing Israeli technology to honor victims of the October 2023 Hamas War. She is also an active member of the 8400 healthtech leadership network.
She played a pivotal role in NeuroDerms successful NASDAQ IPO and its subsequent acquisition by Mitsubishi Tanabe for $1. 1 billion.
Read the full overview →Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.
Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.
Discover additional public profiles from our index.
Looking for someone else? Search here for anyone.